Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 354

1.

ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.

Montañola A, de Retana SF, López-Rueda A, Merino-Zamorano C, Penalba A, Fernández-Álvarez P, Rodríguez-Luna D, Malagelada A, Pujadas F, Montaner J, Hernández-Guillamon M.

Neuromolecular Med. 2016 Mar;18(1):99-108. doi: 10.1007/s12017-015-8381-7. Epub 2015 Dec 14.

PMID:
26661731
2.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

3.

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.

Camacho J, Moliné T, Bonaterra-Pastra A, Ramón Y Cajal S, Martínez-Sáez E, Hernández-Guillamon M.

Front Neurol. 2019 Mar 13;10:187. doi: 10.3389/fneur.2019.00187. eCollection 2019.

4.

High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.

Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV.

Ann Neurol. 1997 Jun;41(6):716-21.

PMID:
9189032
5.
6.

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

McCarron MO, Nicoll JA.

Ann N Y Acad Sci. 2000 Apr;903:176-9. Review.

PMID:
10818505
7.

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.

Miners JS, Clarke P, Love S.

Brain Pathol. 2017 May;27(3):305-313. doi: 10.1111/bpa.12392. Epub 2016 Jul 8.

PMID:
27248362
8.

The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.

Cacciottolo M, Christensen A, Moser A, Liu J, Pike CJ, Smith C, LaDu MJ, Sullivan PM, Morgan TE, Dolzhenko E, Charidimou A, Wahlund LO, Wiberg MK, Shams S, Chiang GC; Alzheimer's Disease Neuroimaging Initiative, Finch CE.

Neurobiol Aging. 2016 Jan;37:47-57. doi: 10.1016/j.neurobiolaging.2015.10.010. Epub 2015 Oct 19.

9.

Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.

Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T.

Acta Neuropathol. 2016 Aug;132(2):225-34. doi: 10.1007/s00401-016-1580-y. Epub 2016 May 14.

10.

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.

Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kölsch H, Del Tredici K, Attems J, Ghebremedhin E.

Acta Neuropathol. 2010 Aug;120(2):169-83. doi: 10.1007/s00401-010-0707-9. Epub 2010 Jun 10.

PMID:
20535486
11.

Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.

Hondius DC, Eigenhuis KN, Morrema THJ, van der Schors RC, van Nierop P, Bugiani M, Li KW, Hoozemans JJM, Smit AB, Rozemuller AJM.

Acta Neuropathol Commun. 2018 Jun 4;6(1):46. doi: 10.1186/s40478-018-0540-2.

12.

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT.

Ann Neurol. 1995 Aug;38(2):254-9.

PMID:
7654074
13.

The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.

Alaylıoğlu M, Gezen-Ak D, Dursun E, Bilgiç B, Hanağası H, Ertan T, Gürvit H, Emre M, Eker E, Uysal Ö, Yılmazer S.

J Geriatr Psychiatry Neurol. 2016 Jul;29(4):221-6. doi: 10.1177/0891988716640373. Epub 2016 Apr 12.

PMID:
27076484
14.

APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.

Nicoll JA, McCarron MO.

Amyloid. 2001 Jul;8 Suppl 1:51-5.

PMID:
11676291
15.
16.

Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy.

Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, Mizusawa H, Yamada M.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):696-9.

17.

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S.

Neuropathol Appl Neurobiol. 2005 Dec;31(6):589-99.

PMID:
16281907
18.

Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.

Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM.

Acta Neuropathol Commun. 2015 Nov 10;3:70. doi: 10.1186/s40478-015-0250-y.

19.

Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.

Wojtas AM, Kang SS, Olley BM, Gatherer M, Shinohara M, Lozano PA, Liu CC, Kurti A, Baker KE, Dickson DW, Yue M, Petrucelli L, Bu G, Carare RO, Fryer JD.

Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6962-E6971. doi: 10.1073/pnas.1701137114. Epub 2017 Jul 12.

20.

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Attems J, Lauda F, Jellinger KA.

J Neurol. 2008 Jan;255(1):70-6. doi: 10.1007/s00415-008-0674-4. Epub 2008 Jan 18.

PMID:
18202817

Supplemental Content

Support Center